Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.

NCT02046031 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Ginkgolides Meglumine Injection

Sponsor

Jiangsu Kanion Pharmaceutical Co., Ltd

Collaborators

[object Object]